Medical educators have used machine learning to reconsider—and ultimately select—some 20 qualified residents who had been screened out by human reviewers at their institution.

True or false? Each time a software developer significantly updates an FDA-approved Software as a Medical Device product, the SaMD faces possible re-review by the agency.

The academic medical institution that maintains the world’s best-stocked library of curated, patient-deidentified and AI-ready data is going 100% open source with its digital riches.

Patients are strongly inclined to follow treatment instructions that combine innovative AI recommendations with a physician’s reassuring presence.

If humans and only humans can be named inventors on U.S. patent applications, some AI developers are going to be disincentivized from innovating.

Researchers have used deep learning to assess three key biomarkers of existing breast cancers on routinely acquired histology slides. In the process, the team has advanced AI-based biomarker analysis for managing a range of cancers.

The bioprinted replicas can preview a given tumor’s reaction to specific therapies and combinations thereof.

Along with a curated and annotated image dataset, the share includes code, network architecture and trained model weights.